{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T20:51:51Z","timestamp":1772225511506,"version":"3.50.1"},"reference-count":44,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"34","license":[{"start":{"date-parts":[[2023,8,25]],"date-time":"2023-08-25T00:00:00Z","timestamp":1692921600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,8,25]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Xihuang Pills\/Capsules have a longstanding history of utilization in traditional Chinese medicine (TCM) for treating cancer. Nevertheless, a comprehensive investigation is required regarding the specific impacts and safety of Xihuang Pills\/Capsules in individuals with uterine cervical neoplasms. Thus, conducting a meta-analysis is essential to evaluate the clinical effectiveness of combining Xihuang Pills\/Capsules with Western medicine in patients with cervical neoplasms.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>The research involved searching 5 English and 4 Chinese databases for randomized controlled trials (RCTs) investigating the use of Xihuang Pills\/Capsules in conjunction with Western medicine for treating uterine cervical neoplasms. Subsequently, statistical analysis was carried out using Review Manager software (version 5.3).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>This research encompassed 10 RCTs involving 937 patients. The findings revealed that the combination of Xihuang Pills\/Capsules with Western medicine treatment led to improvements in various aspects of the patients\u2019 condition. Specifically, there was an enhancement in the short-term efficacy rate (risk ratio [RR] = 1.14, 95% confidence interval [CI]: 1.06\u20131.22, <jats:italic toggle=\"yes\">P<\/jats:italic> = .0003), Karnofsky performance score (KPS) (mean difference [MD] = 5.90, 95% CI: 0.54\u201311.26, <jats:italic toggle=\"yes\">P<\/jats:italic> = .03), survival rates, CD3+, CD3 + CD4+, CD3 + CD8+, CD3\u2013CD56 + cells, and immunoglobulin M in patients with uterine cervical neoplasms. Moreover, the combination treatment resulted in a reduction of adverse reactions, including gastrointestinal reactions (RR = 0.52, 95% CI: 0.42\u20130.64, <jats:italic toggle=\"yes\">P<\/jats:italic> &lt; .00001), radiation proctitis (RR = 0.47, 95% CI: 0.33\u20130.68, <jats:italic toggle=\"yes\">P<\/jats:italic> &lt; .0001), myelosuppression (RR = 0.41, 95% CI: 0.26\u20130.64, <jats:italic toggle=\"yes\">P<\/jats:italic> &lt; .0001), as well as carcinoembryonic antigen (CEA) and squamous cell carcinoma antigen (SCC-Ag) levels. Additionally, the treatment exhibited an inhibitory effect on white blood cells (WBCs) and platelets (PLTs).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>The amalgamation of Xihuang Pills\/Capsules with conventional anti-tumor therapy proves to be both effective and safe in the treatment of cervical neoplasms. However, further validation through high-quality RCTs is necessary to substantiate these findings.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000034846","type":"journal-article","created":{"date-parts":[[2023,8,30]],"date-time":"2023-08-30T22:01:24Z","timestamp":1693432884000},"page":"e34846","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Meta-analysis of the efficacy and safety of Xihuang Pills\/capsules in adjuvant treatment of uterine cervical neoplasms"],"prefix":"10.1097","volume":"102","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2113-7260","authenticated-orcid":false,"given":"Huirong","family":"Xu","sequence":"first","affiliation":[{"name":"College of Traditional Chinese Medicine, Shandong University of Traditional Chinese Medicine, Jinan, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guangyu","family":"Tian","sequence":"additional","affiliation":[{"name":"College of Traditional Chinese Medicine, Shandong University of Traditional Chinese Medicine, Jinan, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunli","family":"Wu","sequence":"additional","affiliation":[{"name":"College of Traditional Chinese Medicine, Shandong University of Traditional Chinese Medicine, Jinan, P.R. China"},{"name":"Jinan city Hospital of Integrated Traditional Chinese and Western Medicine, Jinan, P.R. China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaowen","family":"Sun","sequence":"additional","affiliation":[{"name":"College of Traditional Chinese Medicine, Shandong University of Traditional Chinese Medicine, Jinan, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0219-0632","authenticated-orcid":false,"given":"Kejian","family":"Li","sequence":"additional","affiliation":[{"name":"College of Traditional Chinese Medicine, Shandong University of Traditional Chinese Medicine, Jinan, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21708","article-title":"Cancer statistics, 2022.","volume":"72","author":"Siegel","year":"2022","journal-title":"CA Cancer J Clin"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1002\/ijc.34250","article-title":"Dickkopf-1 expression is repressed by oncogenic human papillomaviruses (HPVs) and regulates the Cisplatin sensitivity of HPV-positive cancer cells in a JNK-dependent manner.","volume":"151","author":"Frensemeier","year":"2022","journal-title":"Int J Cancer"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"e191","DOI":"10.1016\/S2214-109X(19)30482-6","article-title":"Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis.","volume":"8","author":"Arbyn","year":"2020","journal-title":"Lancet Glob Health"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"849352","DOI":"10.3389\/fonc.2022.849352","article-title":"PD-1\/PD-L1 inhibitors for advanced or metastatic cervical cancer: from bench to bed.","volume":"12","author":"Huang","year":"2022","journal-title":"Front Oncol"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"100565","DOI":"10.1016\/j.esmoop.2022.100565","article-title":"A phase III randomized, controlled trial of nedaplatin versus cisplatin concurrent chemoradiotherapy in patients with cervical cancer.","volume":"7","author":"Yang","year":"2022","journal-title":"ESMO Open"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"e0266001","DOI":"10.1371\/journal.pone.0266001","article-title":"Clinical outcome of FIGO 2018 stage IB3\/IIA2 cervical cancer treated by neoadjuvant chemotherapy followed by radical surgery due to lack of radiotherapy equipment: a retrospective comparison with concurrent chemoradiotherapy.","volume":"17","author":"Zeng","year":"2022","journal-title":"PLoS One"},{"key":"R7-20250504","first-page":"310","article-title":"Efficacy and safety of PEG-rhG-CSF in preventing chemoradiotherapy-induced neutropenia in patients with locally advanced cervical cancer.","volume":"23","author":"Li","year":"2023","journal-title":"Biomol Biomed"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"993443","DOI":"10.3389\/fpubh.2022.993443","article-title":"Development of a nomogram for predicting grade 2 or higher acute hematologic toxicity of cervical cancer after the pelvic bone marrow sparing radiotherapy.","volume":"10","author":"Meng","year":"2022","journal-title":"Front Public Health"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1136\/ijgc-2019-000690","article-title":"Consolidation chemotherapy in early-stage cervical cancer patients with lymph node metastasis after radical hysterectomy.","volume":"30","author":"Zhong","year":"2020","journal-title":"Int J Gynecol Cancer"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"5957","DOI":"10.7314\/APJCP.2015.16.14.5957","article-title":"A randomized controlled trial comparing clinical outcomes and toxicity of lobaplatin- versus cisplatin-based concurrent chemotherapy plus radiotherapy and high-dose-rate brachytherapy for FIGO stage II and III cervical cancer.","volume":"16","author":"Wang","year":"2015","journal-title":"Asian Pac J Cancer Prev"},{"key":"R11-20250504","first-page":"1298","article-title":"Efficacy of helical tomotherapy combined with CT-guided three-dimensional intracavitary brachytherapy in treatment of locally advanced cervical cancer.","volume":"26","author":"Ye","year":"2021","journal-title":"J Buon"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"113345","DOI":"10.1016\/j.biopha.2022.113345","article-title":"Cellular landscaping of cisplatin resistance in cervical cancer.","volume":"153","author":"Bhattacharjee","year":"2022","journal-title":"Biomed Pharmacother"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"730753","DOI":"10.3389\/fonc.2021.730753","article-title":"Neoadjuvant chemotherapy followed by surgery versus abdominal radical hysterectomy alone for oncological outcomes of stage IB3 cervical cancer-a propensity score matching analysis.","volume":"11","author":"Li","year":"2021","journal-title":"Front Oncol"},{"key":"R14-20250504","first-page":"1497","article-title":"Inheritance and development of traditional chinese medicine oncology-from reinforcing healthy qi and consolidating root to regulating qi and removing toxin (\u4e2d\u533b\u80bf\u7624\u7406\u8bba\u4f20\u627f\u53d1\u5c55\u5386\u7a0b\u2014\u2014\u201c\u6276\u6b63\u57f9\u672c\u201d\u5230\u201c\u8c03\u6c14\u89e3\u6bd2\u201d).","volume":"17","author":"Guo","year":"2022","journal-title":"World Chin Med"},{"key":"R15-20250504","first-page":"130","article-title":"Discussion on TCM prevention and treatment of malignant tumor based on the idea of \u201cRemoving bad accumulation by strengthening healthy energy\u201d (\u57fa\u4e8e\u201c\u517b\u6b63\u79ef\u81ea\u9664\u201d\u601d\u60f3\u63a2\u8ba8\u6076\u6027\u80bf\u7624\u7684\u4e2d\u533b\u9632\u6cbb).","volume":"14","author":"Zhang","year":"2022","journal-title":"Clin J Chin Med"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"152","DOI":"10.4103\/wjtcm.wjtcm_6_20","article-title":"Xihuang pills, a traditional Chinese preparation used as a complementary medicine to treat cancer: an updated review.","volume":"6","author":"Bailly","year":"2020","journal-title":"World J Tradit Chin Med"},{"key":"R17-20250504","first-page":"725","article-title":"Based on BATMAN-TCM to explore the molecular mechanism of Xihuang Pill regulating immune function to treat breast precancerous lesions.","volume":"13","author":"Li","year":"2021","journal-title":"Breast Cancer (Dove Med Press)"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"5936086","DOI":"10.1155\/2017\/5936086","article-title":"Clinical effects of Xihuang Pill combined with chemotherapy in patients with advanced colorectal cancer.","volume":"2017","author":"Yu","year":"2017","journal-title":"Evid Based Complement Alternat Med"},{"key":"R19-20250504","first-page":"76","article-title":"Effect of Xihuang Pills combined with TP chemotherapy on tumor markers and Th1\/Th2 cytokines in patients with advanced ovarian cancer (\u897f\u9ec4\u4e38\u8054\u5408TP\u5316\u7597\u65b9\u6848\u5bf9\u665a\u671f\u5375\u5de2\u764c\u60a3\u8005\u80bf\u7624\u6807\u5fd7\u7269\u53caTh1\/Th2\u7ec6\u80de\u56e0\u5b50\u7684\u5f71\u54cd).","volume":"18","author":"Cheng","year":"2021","journal-title":"Med Innov China"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"697247","DOI":"10.3389\/fonc.2021.697247","article-title":"An integrative metabolomic and network pharmacology study revealing the regulating properties of Xihuang Pill that improves anlotinib effects in lung cancer.","volume":"11","author":"Li","year":"2021","journal-title":"Front Oncol"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"872","DOI":"10.4251\/wjgo.v14.i4.872","article-title":"Xihuang pills induce apoptosis in hepatocellular carcinoma by suppressing phosphoinositide 3-kinase\/protein kinase-B\/mechanistic target of rapamycin pathway.","volume":"14","author":"Teng","year":"2022","journal-title":"World J Gastrointest Oncol"},{"key":"R22-20250504","first-page":"90","article-title":"Treatment of chronic lymphocytic leukemia by releasing hardenings and nodules in 1 case (\u6d88\u7665\u6563\u7ed3\u6cd5\u6cbb\u7597\u6162\u6027\u6dcb\u5df4\u7ec6\u80de\u767d\u8840\u75c51\u4f8b).","volume":"39","author":"Li","year":"2020","journal-title":"Beijing J Tradit Chin Med"},{"key":"R23-20250504","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews.","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"R24-20250504","first-page":"233","article-title":"Effect of Xihuang capsules assisting in extracorporeal extended field radiotherapy on life cycle and serum levels of miR-155 and miR-24 in elderly patients with cervical cancer (\u897f\u9ec4\u80f6\u56ca\u8f85\u52a9\u4f53\u5916\u5ef6\u4f38\u91ce\u653e\u7597\u5bf9\u8001\u5e74\u5bab\u9888\u764c\u751f\u5b58\u5468\u671f\u53ca\u8840\u6e05 miR-155\u3001miR-24 \u6c34\u5e73\u7684\u4f5c\u7528).","volume":"40","author":"Zhang","year":"2022","journal-title":"Chin Arch Tradit Chin Med"},{"key":"R25-20250504","first-page":"496","article-title":"Therapeutic effects of Xihuang capsules combined with radiotherapy on gerontal patients with cervical carcinoma (\u897f\u9ec4\u80f6\u56ca\u8054\u5408\u653e\u7597\u6cbb\u7597\u8001\u5e74\u5bab\u9888\u764c).","volume":"36","author":"Tai","year":"2017","journal-title":"J Hubei Univ Med"},{"key":"R26-20250504","first-page":"169","article-title":"Effect observation of Xihuang capsules combined with gemcitabine for advanced cervical cancer (\u897f\u9ec4\u80f6\u56ca\u8054\u5408\u5409\u897f\u4ed6\u6ee8\u6cbb\u7597\u665a\u671f\u5bab\u9888\u764c\u7597\u6548\u89c2\u5bdf).","volume":"50","author":"Peng","year":"2018","journal-title":"J New Chin Med"},{"key":"R27-20250504","first-page":"3007","article-title":"Efficacy observation of Xihuang capsules combined with image-guided radiotherapy for intermediate and advanced uterine cervical neoplasms (\u897f\u9ec4\u80f6\u56ca\u8054\u5408\u56fe\u50cf\u5f15\u5bfc\u653e\u5c04\u6cbb\u7597\u4e2d\u665a\u671f\u5bab\u9888\u764c\u7597\u6548\u89c2\u5bdf).","volume":"26","author":"Qiu","year":"2017","journal-title":"Mod J Integr Tradit Chin West Med"},{"key":"R28-20250504","first-page":"78","article-title":"The efficacy observation of Xihuang capsules combined with radiation therapy for 45 cases of intermediate and advanced uterine cervical neoplasms (\u897f\u9ec4\u80f6\u56ca\u914d\u5408\u653e\u5c04\u6cbb\u7597\u4e2d\u665a\u671f\u5bab\u9888\u764c45\u4f8b\u7597\u6548\u89c2\u5bdf).","volume":"37","author":"Li","year":"2009","journal-title":"Acta Chin Med Pharmacol"},{"key":"R29-20250504","first-page":"2916","article-title":"Effect of Xihuang Pills on the short-term efficacy of three-dimensional conformal radiotherapy combined with intraluminal post-loading radiotherapy in the treatment of intermediate and advanced uterine cervical neoplasms (\u897f\u9ec4\u4e38\u5bf9\u4e09\u7ef4\u9002\u5f62\u653e\u7597\u8054\u5408\u8154\u5185\u540e\u88c5\u653e\u7597\u6cbb\u7597\u4e2d\u665a\u671f\u5bab\u9888\u764c\u8fd1\u671f\u7597\u6548\u5f71\u54cd).","volume":"25","author":"Chen","year":"2016","journal-title":"Mod J Integr Tradit Chin West Med"},{"key":"R30-20250504","first-page":"11","article-title":"Analysis of the effect of Xihuangwan combined with TP chemotherapy on advanced cervical cancer (\u897f\u9ec4\u4e38\u8054\u5408TP\u65b9\u6848\u5316\u7597\u5bf9\u665a\u671f\u5bab\u9888\u764c\u6548\u679c\u5206\u6790).","volume":"39","author":"Zhang","year":"2020","journal-title":"China Foreign Med Treat"},{"key":"R31-20250504","first-page":"1215","article-title":"Effect of Xihuang Pills combined with concurrent chemoradiotherapy on locally advanced cervical cancer (\u897f\u9ec4\u4e38\u8054\u5408\u540c\u6b65\u653e\u5316\u7597\u6cbb\u7597\u5c40\u90e8\u5bab\u9888\u764c\u7684\u4e34\u5e8a\u7814\u7a76).","volume":"11","author":"Chen","year":"2016","journal-title":"World Chin Med"},{"key":"R32-20250504","first-page":"154","article-title":"Clinical study of Xihuang capsules in preventing radiation proctitis (\u897f\u9ec4\u80f6\u56ca\u9884\u9632\u653e\u5c04\u6027\u76f4\u80a0\u708e\u7684\u4e34\u5e8a\u7814\u7a76).","volume":"9","author":"Zhang","year":"2018","journal-title":"Heilongjiang Sci"},{"key":"R33-20250504","first-page":"1112","article-title":"Effect of Xihuang Pills on curative effect of paclitaxel combined with platinum based neoadjuvant chemotherapy in patients with advanced cervical cancer after operation (\u897f\u9ec4\u4e38\u8054\u5408\u7d2b\u6749\u9187\u548c\u94c2\u7c7b\u65b0\u8f85\u52a9\u5316\u7597\u5bf9\u665a\u671f\u5bab\u9888\u764c\u60a3\u8005\u672f\u540e\u7597\u6548\u7684\u5f71\u54cd).","volume":"40","author":"Sang","year":"2017","journal-title":"Drug Eval Res"},{"key":"R34-20250504","doi-asserted-by":"crossref","first-page":"948","DOI":"10.5603\/RPOR.a2021.0115","article-title":"Weekly vs. tri-weekly cisplatin based chemoradiation in carcinoma cervix: a prospective randomized study of toxicity and compliance.","volume":"26","author":"Katke","year":"2021","journal-title":"Rep Pract Oncol Radiother"},{"key":"R35-20250504","doi-asserted-by":"crossref","first-page":"926840","DOI":"10.3389\/fonc.2022.926840","article-title":"Analysis of treatment outcomes and prognosis after concurrent chemoradiotherapy for locally advanced cervical cancer.","volume":"12","author":"Peng","year":"2022","journal-title":"Front Oncol"},{"key":"R36-20250504","doi-asserted-by":"crossref","first-page":"5936773","DOI":"10.1155\/2022\/5936773","article-title":"Efficacy and side effects of irinotecan combined with nedaplatin versus paclitaxel combined with cisplatin in neoadjuvant chemotherapy for locally advanced cervical cancer and tumor marker analysis: based on a retrospective analysis.","volume":"2022","author":"Jiang","year":"2022","journal-title":"Comput Math Methods Med"},{"key":"R37-20250504","doi-asserted-by":"crossref","first-page":"9578436","DOI":"10.1155\/2022\/9578436","article-title":"A retrospective study of chemotherapy and 3d-image-guided afterloading intracavitary radiotherapy in locally advanced cervical cancer.","volume":"2022","author":"Li","year":"2022","journal-title":"J Oncol"},{"key":"R38-20250504","doi-asserted-by":"crossref","first-page":"8307","DOI":"10.2147\/CMAR.S328309","article-title":"A comparison of different schemes of neoadjuvant chemotherapy followed by concurrent chemotherapy and radiotherapy for locally advanced cervical cancer: a retrospective study.","volume":"13","author":"Tian","year":"2021","journal-title":"Cancer Manag Res"},{"key":"R39-20250504","doi-asserted-by":"crossref","first-page":"3502460","DOI":"10.1155\/2019\/3502460","article-title":"Meta-analysis of Xihuang Pill efficacy when combined with chemotherapy for treatment of breast cancer.","volume":"2019","author":"Mao","year":"2019","journal-title":"Evid Based Complement Alternat Med"},{"key":"R40-20250504","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s12929-022-00866-3","article-title":"Tumor microenvironment: barrier or opportunity towards effective cancer therapy.","volume":"29","author":"Tiwari","year":"2022","journal-title":"J Biomed Sci"},{"key":"R41-20250504","doi-asserted-by":"crossref","first-page":"698","DOI":"10.3390\/vaccines11030698","article-title":"Outcomes of high-grade cervical dysplasia with positive margins and HPV persistence after cervical conization.","volume":"11","author":"Giannini","year":"2023","journal-title":"Vaccines (Basel)"},{"key":"R42-20250504","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ygyno.2023.04.030","article-title":"Ten-year outcomes following laparoscopic and open abdominal radical hysterectomy for \u201clow-risk\u201d early-stage cervical cancer: a propensity-score based analysis.","volume":"174","author":"Di Donato","year":"2023","journal-title":"Gynecol Oncol"},{"key":"R43-20250504","first-page":"250","article-title":"Anti-tumor application and pharmacological mechanism of Xihuangwan: a review (\u897f\u9ec4\u4e38\u6297\u80bf\u7624\u4e34\u5e8a\u5e94\u7528\u53ca\u836f\u7406\u4f5c\u7528\u673a\u5236\u7814\u7a76\u8fdb\u5c55).","volume":"28","author":"Yang","year":"2022","journal-title":"Chin J Exp Tradit Med Formulae"},{"key":"R44-20250504","doi-asserted-by":"crossref","first-page":"283","DOI":"10.5582\/bst.2021.01318","article-title":"The positive role of traditional Chinese medicine as an adjunctive therapy for cancer.","volume":"15","author":"Zhang","year":"2021","journal-title":"Biosci Trends"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000034846","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T03:02:35Z","timestamp":1746327755000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000034846"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,25]]},"references-count":44,"journal-issue":{"issue":"34","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000034846","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,25]]}}}